Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Claudin expression is dysregulated in prostate adenocarcinomas but does not correlate with main clinicopathological parameters

Full text
Author(s):
Coutinho-Camillo, Claudia Malheiros [1] ; Lourenco, Silvia Vanessa [2] ; da Fonseca, Francisco Paulo [3] ; Soares, Fernando Augusto [1, 2]
Total Authors: 4
Affiliation:
[1] Hosp AC Camargo Fund Antonio Prudente, Dept Anat Patol, BR-01509010 Sao Paulo - Brazil
[2] Univ Sao Paulo, Sch Dent, Discipline Gen Pathol, Sao Paulo - Brazil
[3] Hosp AC Camargo Fund Antonio Prudente, Div Urol, Dept Pelv Surg, BR-01509010 Sao Paulo - Brazil
Total Affiliations: 3
Document type: Journal article
Source: PATHOLOGY; v. 43, n. 2, p. 143-148, FEB 2011.
Web of Science Citations: 7
Abstract

Aims: Claudins, a large family of essential tight junction (TJ) proteins, are abnormally regulated in human carcinomas. The aim of this study was to determine the expression of claudins 1, 2, 3, 4, 5, 7, and 11 in prostate samples from Brazilian patients and correlate it with the clinicopathological features of prostate cancer. Methods: Using a tissue microarray (TMA) of specimens of prostate adenocarcinoma and benign prostatic hyperplasia (BPH) we analysed the expression of claudins 1, 2, 3, 4, 5, 7, and 11 by immunohistochemistry. Results: Claudin 4 was down-regulated and claudins 2, 3, and 5 were overexpressed in prostate adenocarcinomas compared with BPH samples. Expression of claudins 1 and 7 was similar in tumours and BPH samples. Claudin 11 was absent from all prostate samples. Overexpression of claudin 3 was associated with perineural invasion (p = 0.014) and tended to occur in advanced stages of the disease (p = 0.064). Increased expression of claudin 5 was marginally associated with perineural invasion (p = 0.060). Conclusions: Our results suggest that alterations in claudin expression occur in prostate cancer cells, although we have not found an association with the main clinicopathological parameters. (AU)

FAPESP's process: 98/14335-2 - Antonio Prudente Cancer Research Center
Grantee:Fernando Augusto Soares
Support Opportunities: Research Grants - Research, Innovation and Dissemination Centers - RIDC